OxyBand Technologies, Inc. is the first company to package pure oxygen into a discrete traditional wound dressing, using a directionally permeable gas emitting reservoir. OxyBand™ wound dressing is the only FDA-approved wound dressing proven to continuously deliver pure oxygen to damaged tissue for up to 5 days. Testing with OxyBand™ demonstrated significantly faster healing, less pain, less exudate, reduced redness and reduced initial scarring on standardized laser burn wounds compared to control dressings. Additional studies have further demonstrated the efficacy of OxyBand™ on other types of wounds at a major academic medical institution. The United States Army Institute for Surgical Research conducted a clinical trial evaluating the efficacy of OxyBand. According to the published results, OxyBand Wound Dressing; significantly accelerated healing by at least 3 days (25%) & significantly reduced pain at the wound site for larger donor site wounds without any infection compared to the standard of care. (Journal of Burn Care & Research, Supplement, March 2013). OxyBand Technologies Inc. develops proprietary patented bio medical technologies from concept to market that provide therapeutic gases such as oxygen and nitric oxide in device applications for traumatic & other acute wounds, diabetic & chronic skin ulcers, eye diseases, orthopedics, regenerative medicine, antimicrobial healing & cosmetic procedures among others. OxyBand has a comprehensive patent portfolio, a pipeline and an FDA approved unique medical device, OxyBand Wound Dressing; that in three clinical trials has been shown to heal wounds faster with less pain & inflammation & without any infection compared to standard of care and placebo (Poulos et al., Lairet, et. al).